Resonance Specialties Limited (BOM:524218)

Market Cap	1.60B +21.7%
Revenue (ttm)	902.48M +16.0%
Net Income	103.96M +58.3%
EPS	9.01 +58.4%
Shares Out	11.54M
PE Ratio	15.37
Forward PE	n/a
Dividend	1.00 (0.72%)
Ex-Dividend Date	Jul 28, 2026

Volume	16,925
Open	136.05
Previous Close	139.85
Day's Range	136.05 - 140.00
52-Week Range	77.00 - 147.45
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate,...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 66
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524218

Financial Performance

In fiscal year 2026, Resonance Specialties's revenue was 902.48 million, an increase of 15.99% compared to the previous year's 778.07 million. Earnings were 103.96 million, an increase of 58.32%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 21, 2026

Data Sources Report a data error